Nermine M Abd Raboh1, Sarah A Hakim1. 1. Department of Pathology, Faculty of Medicine, Ain Shams University Abbasseya square, Cairo, Egypt.
Abstract
BACKGROUND: The differential diagnosis of salivary carcinomas is always difficult and challenging. Salivary neoplasms often shows more than one growth pattern and significant morphologic variability may exist within a single tumor and between different tumors. The aim of this study was to examine the role of DOG1 (discovered on gastrointestinal tumor-1) and p63 immunohistochemistry in the diagnosis and differential diagnosis of salivary carcinomas. METHODS: we examined the expression of DOG1 and p63 immunohistochemistry in 33 mucoepidermoid carcinomas (MEC), 9 acinic cell carcinomas (ACC), 10 adenoid cystic carcinomas (AdCC) and 4 myoepithelial carcinomas. RESULTS: All ACC showed strong to moderate positivity for DOG1 (P=0.001) and all were totally negative for p63. All MEC expressed strong to moderate positivity for p63 (P=0.001) while only (9.1%) were weak to moderately positive for DOG1. (80%) AdCC were moderately positive for DOG1 in ductal and myoepithelial components and (100%) showed moderate positivity for p63 in myoepithelial cells only (P=0.001). All myoepithelial carcinomas were DOG1 negative, 2 (50%) were weakly positive for p63 while the other 2 were moderately positive (P=0.5). CONCLUSION: DOG1 is a sensitive marker in the diagnosis of acinic cell carcinoma, p63 is sensitive in the diagnosis of mucoepidermoid carcinoma, the combined use of both markers is helpful and statistically significant in the differential diagnosis of acinic cell carcinoma versus mucoepidermoid carcinoma, both markers can help in the diagnosis of adenoid cystic carcinoma but they have no role in the diagnosis of myoepithelial carcinoma.
BACKGROUND: The differential diagnosis of salivary carcinomas is always difficult and challenging. Salivary neoplasms often shows more than one growth pattern and significant morphologic variability may exist within a single tumor and between different tumors. The aim of this study was to examine the role of DOG1 (discovered on gastrointestinal tumor-1) and p63 immunohistochemistry in the diagnosis and differential diagnosis of salivary carcinomas. METHODS: we examined the expression of DOG1 and p63 immunohistochemistry in 33 mucoepidermoid carcinomas (MEC), 9 acinic cell carcinomas (ACC), 10 adenoid cystic carcinomas (AdCC) and 4 myoepithelial carcinomas. RESULTS: All ACC showed strong to moderate positivity for DOG1 (P=0.001) and all were totally negative for p63. All MEC expressed strong to moderate positivity for p63 (P=0.001) while only (9.1%) were weak to moderately positive for DOG1. (80%) AdCC were moderately positive for DOG1 in ductal and myoepithelial components and (100%) showed moderate positivity for p63 in myoepithelial cells only (P=0.001). All myoepithelial carcinomas were DOG1 negative, 2 (50%) were weakly positive for p63 while the other 2 were moderately positive (P=0.5). CONCLUSION:DOG1 is a sensitive marker in the diagnosis of acinic cell carcinoma, p63 is sensitive in the diagnosis of mucoepidermoid carcinoma, the combined use of both markers is helpful and statistically significant in the differential diagnosis of acinic cell carcinoma versus mucoepidermoid carcinoma, both markers can help in the diagnosis of adenoid cystic carcinoma but they have no role in the diagnosis of myoepithelial carcinoma.
Authors: A Yang; M Kaghad; Y Wang; E Gillett; M D Fleming; V Dötsch; N C Andrews; D Caput; F McKeon Journal: Mol Cell Date: 1998-09 Impact factor: 17.970
Authors: Heikki Luukkaa; Pekka Klemi; Ilmo Leivo; Petri Koivunen; Jussi Laranne; Antti Mäkitie; Jukka Virtaniemi; Susanna Hinkka; Reidar Grénman Journal: Acta Otolaryngol Date: 2005-02 Impact factor: 1.494
Authors: Jiraporn Ousingsawat; Joana R Martins; Rainer Schreiber; Jason R Rock; Brian D Harfe; Karl Kunzelmann Journal: J Biol Chem Date: 2009-08-13 Impact factor: 5.157
Authors: Robert B West; Christopher L Corless; Xin Chen; Brian P Rubin; Subbaya Subramanian; Kelli Montgomery; Shirley Zhu; Catherine A Ball; Torsten O Nielsen; Rajiv Patel; John R Goldblum; Patrick O Brown; Michael C Heinrich; Matt van de Rijn Journal: Am J Pathol Date: 2004-07 Impact factor: 4.307
Authors: Hussein A Abbas; Ngoc Hoang Bao Bui; Kimal Rajapakshe; Justin Wong; Preethi Gunaratne; Kenneth Y Tsai; Cristian Coarfa; Elsa R Flores Journal: Cancer Res Date: 2017-11-27 Impact factor: 12.701
Authors: Fernanda Viviane Mariano; Camila Andrea Concha Gómez; Juliana de Souza do Nascimento; Harim Tavares Dos Santos; Erika Said Egal; Victor Angelo Martins Montalli; Pablo Agustin Vargas; Oslei Paes de Almeida; Albina Altemani Journal: Head Neck Pathol Date: 2016-05-13
Authors: C Christofer Juhlin; Sylvia L Asa; Kenbugul Jatta; Homeyra Naserhojati Rodsari; Ivan Shabo; Felix Haglund; Brett Delahunt; Hemamali Samaratunga; Lars Egevad; Anders Höög; Jan Zedenius Journal: Head Neck Pathol Date: 2020-06-09